Stay updated on Safety of DCR HBVS in Hepatitis B - Clinical Trial
Sign up to get notified when there's something new on the Safety of DCR HBVS in Hepatitis B - Clinical Trial page.

Latest updates to the Safety of DCR HBVS in Hepatitis B - Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe screenshots show the same Study Details page with only minor visual or layout adjustments; core content such as the study title, conditions, enrollment, locations, and outcome measures appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoNo Change Detected
- Check43 days agoChange DetectedMajor update: version bumped to v3.2.0 and a critical new government funding/operating status notice added; previous v3.1.0 reference removed.SummaryDifference2%

- Check50 days agoChange DetectedUpdated to Revision v3.1.0 and removal of multiple drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs), indicating content pruning in the drug-safety area and a new version tag.SummaryDifference0.3%

- Check64 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1, signaling a new release; the 'Back to Top' element was removed as a minor UI change.SummaryDifference0.1%

- Check71 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%

- Check78 days agoChange DetectedThe web page has been updated to include specific facility names and locations, particularly highlighting Seoul, South Korea, and relevant publications related to drug safety and pathological conditions. Additionally, the revision number has been updated to v3.0.0.SummaryDifference9%

Stay in the know with updates to Safety of DCR HBVS in Hepatitis B - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of DCR HBVS in Hepatitis B - Clinical Trial page.